BusinessAlimera Sciences to Present at the 38th Annual Cowen & Co. Health Care ConferenceBy Nasdaq OMXFeb 27, 2018, 12:30 PM UTC
BusinessEyenovia, Inc. announces publication of Phase II study results demonstrating benefits of micro-formulation over conventional eyedroppers and addition of Scientific Advisory Board membersBy Nasdaq OMXNov 28, 2016, 8:47 PM UTC
